Diabetes Mellitus, Type 1, TrialNet, T1D, Type 1 Diabetes Mellitus, Thymoglobulin, Antilymphocyte Serum, Antithymocyte Globulin, Antithymocyte globulin (ATG)
Lead Scientist at UCSF
- Stephen Gitelman, MD
Dr. Gitelman is a physician scientist involved in studies to determine what causes type 1 diabetes mellitus (T1DM), and in clinical trials to prevent disease development, or preserve beta cell function in those recently diagnosed. To this end, he has been an active investigator in the NIH-sponsored TrialNet and Immune Tolerance Network consortia, and other immunotherapy trials in T1DM.